InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Smaldone Alsup Laurie, Director. Officer active across 2 companies, notably Theravance Biopharma, Inc.. Aggregated, 7 filings have been published. Activity tracked since 26 April 2022. The latest transaction was disclosed on 19 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
Laurie Smaldone Alsup is a Board Member at Theravance Biopharma, Inc. With experience in the biopharmaceutical sector, she contributes to the company's strategy and governance. Her role involves overseeing operations and ensuring that decisions made align with the company's objectives.